Insights

Market Expansion Growing female-founded gyne health startup with a rapidly expanding product ecosystem and plans to monitor and improve health via a smartphone, indicating opportunities to sell digital health tools, wearables integration, and telehealth partnerships to health plans, clinics, and consumer brands focusing on women's health.

Sustainability & Impact Mission to close the gender health gap and focus on under-served conditions like endometriosis, PCOS, and menopause presents a selling point for impact-driven funders, government programs, and healthcare networks seeking ESG-aligned investments and partnerships in women’s health.

Tech Stack Proven digital infrastructure including PWA and cloud-based tools (Metabase, Prismic, Cloudflare, Google Fonts API, Playwright) suggests capacity for API integrations, data analytics services, and developer-friendly collaborations with health IT platforms and e-commerce partners.

Financial Position Revenue in the mid-range hundreds of millions with a modest funding round indicates a scalable business model and potential for white-labeling, co-development deals, or enterprise SaaS components for clinics, pharmacies, and insurers seeking gyne health solutions.

Customer Footprint Strong consumer traction with over 100,000 users and a focus on at-home detection of infections positions Daye for partnerships with retail health channels, pharmacies, and employer wellness programs aiming to offer at-home diagnostic tools and self-care products.

Daye Tech Stack

Daye uses 8 technology products and services including Metabase, Prismic, Cloudflare, and more. Explore Daye's tech stack below.

  • Metabase
    Business Intelligence
  • Prismic
    Content Management System
  • Cloudflare
    Content Management System
  • Google Fonts API
    Font Scripts
  • Playwright
    Frameworks And Libraries
  • TweenMax
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Cloudflare Bot Management
    Security

Daye's Email Address Formats

Daye uses at least 1 format(s):
Daye Email FormatsExamplePercentage
First@yourdaye.comJohn@yourdaye.com
82%
First.Last@yourdaye.comJohn.Doe@yourdaye.com
18%

Frequently Asked Questions

What is Daye's stock symbol?

Minus sign iconPlus sign icon
Daye is a publicly traded company; the company's stock symbol is NAVODAYENT.BO.

What is Daye's official website and social media links?

Minus sign iconPlus sign icon
Daye's official website is yourdaye.com and has social profiles on LinkedInCrunchbase.

How much revenue does Daye generate?

Minus sign iconPlus sign icon
As of July 2026, Daye's annual revenue is estimated to be $100M - $250M.

What is Daye's NAICS code?

Minus sign iconPlus sign icon
Daye's NAICS code is 92312 - Administration of Public Health Programs.

How many employees does Daye have currently?

Minus sign iconPlus sign icon
As of July 2026, Daye has approximately 114 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Operations Officer: A. P.Chief Technology Officer: E. C.Head Of Customer Care: S. D.. Explore Daye's employee directory with LeadIQ.

What industry does Daye belong to?

Minus sign iconPlus sign icon
Daye operates in the Public Health industry.

What technology does Daye use?

Minus sign iconPlus sign icon
Daye's tech stack includes MetabasePrismicCloudflareGoogle Fonts APIPlaywrightTweenMaxPWACloudflare Bot Management.

What is Daye's email format?

Minus sign iconPlus sign icon
Daye's email format typically follows the pattern of First@yourdaye.com. Find more Daye email formats with LeadIQ.

How much funding has Daye raised to date?

Minus sign iconPlus sign icon
As of July 2026, Daye has raised $17M in funding. The last funding round occurred on Oct 26, 2022 for $12M.

When was Daye founded?

Minus sign iconPlus sign icon
Daye was founded in 2017.
Daye logo

Daye

Public HealthEngland, United Kingdom51-200 Employees

Daye is a mid-sized, London, England-based startup focused on gynecological health within the public health sector. It began with the development of a tampon designed to relieve menstrual cramps, addressing a common issue for people who menstruate. After helping more than 75,000 women and AFAB individuals manage period pain, the company launched a second-generation tampon that supports at-home detection of vaginal infections, STIs, and HPV. In the next five years, Daye aims to expand into under-served gynecological conditions such as endometriosis, PCOS and menopause and build a smartphone-based health ecosystem.

Section iconCompany Overview

Stock Symbol
NAVODAYENT.BO
NAICS Code
92312 - Administration of Public Health Programs
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $17M

    Daye has raised a total of $17M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12Mas a series_a.

  • $100M - $250M

    Daye's revenue is estimated to be in the range of $100M - $250M

Section iconFunding & Financials

  • $17M

    Daye has raised a total of $17M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12Mas a series_a.

  • $100M - $250M

    Daye's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.